These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1267 related items for PubMed ID: 15665015

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Previous cycle cancellation due to poor follicular development as a predictor of ovarian response in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
    Peñarrubia J, Fábregues F, Manau D, Creus M, Carmona F, Casamitjana R, Vanrell JA, Balasch J.
    Hum Reprod; 2005 Mar; 20(3):622-8. PubMed ID: 15608035
    [Abstract] [Full Text] [Related]

  • 3. Inhibin B and anti-Mullerian hormone: markers of ovarian response in IVF/ICSI patients?
    Muttukrishna S, Suharjono H, McGarrigle H, Sathanandan M.
    BJOG; 2004 Nov; 111(11):1248-53. PubMed ID: 15521870
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.
    Bjercke S, Fedorcsak P, Abyholm T, Storeng R, Ertzeid G, Oldereid N, Omland A, Tanbo T.
    Hum Reprod; 2005 Sep; 20(9):2441-7. PubMed ID: 15919773
    [Abstract] [Full Text] [Related]

  • 7. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
    Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I.
    Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the utility of multiple endocrine and ultrasound measures of ovarian reserve in the prediction of cycle cancellation in a high-risk IVF population.
    McIlveen M, Skull JD, Ledger WL.
    Hum Reprod; 2007 Mar; 22(3):778-85. PubMed ID: 17114197
    [Abstract] [Full Text] [Related]

  • 9. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM, Guibourdenche J, Birkhäuser MH, Bersinger NA.
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [Abstract] [Full Text] [Related]

  • 10. Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology.
    La Marca A, Giulini S, Tirelli A, Bertucci E, Marsella T, Xella S, Volpe A.
    Hum Reprod; 2007 Mar; 22(3):766-71. PubMed ID: 17071823
    [Abstract] [Full Text] [Related]

  • 11. [Value of serum inhibin B measurement in predicting ovarian response in controlled ovarian hyperstimulation for in vitro fertilization cycle].
    Chen Y, Yu Q, Zhang YW, He FF, Sun ZY.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16831355
    [Abstract] [Full Text] [Related]

  • 12. Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
    Peñarrubia J, Balasch J, Fábregues F, Carmona F, Casamitjana R, Moreno V, Calafell JM, Vanrell JA.
    Hum Reprod; 2000 Jul; 15(7):1499-504. PubMed ID: 10875856
    [Abstract] [Full Text] [Related]

  • 13. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY, Guu HF, Yi YC, Chen MJ, Ho ES.
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
    Muttukrishna S, McGarrigle H, Wakim R, Khadum I, Ranieri DM, Serhal P.
    BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART).
    La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A.
    Hum Reprod Update; 2010 Oct; 16(2):113-30. PubMed ID: 19793843
    [Abstract] [Full Text] [Related]

  • 18. Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study.
    Polyzos NP, Nelson SM, Stoop D, Nwoye M, Humaidan P, Anckaert E, Devroey P, Tournaye H.
    Fertil Steril; 2013 Aug; 100(2):438-44. PubMed ID: 23602319
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation.
    La Marca A, Malmusi S, Giulini S, Tamaro LF, Orvieto R, Levratti P, Volpe A.
    Hum Reprod; 2004 Dec; 19(12):2738-41. PubMed ID: 15459174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.